Policy & Advocacy Statement on CMS listing 15 additional drugs subject to price negotiations Jan 17, 2025
Policy & Advocacy Post-Election Healthcare and Biotech Outlook: Implications for Massachusetts and Beyond Dec 05, 2024
Policy & Advocacy MassBio Op-Ed in STAT: How to keep the BIOSECURE Act from hobbling U.S. biotech and pharma Sep 12, 2024
Policy & Advocacy MassBio testifies in support of H.B. 4459’s Life Sciences Initiative reauthorization May 07, 2024
Policy & Advocacy State leaders highlight intersection of policy, partnerships, and patients at MassBio Breakfast Feb 08, 2024
Policy & Advocacy Patients, Policy and the IRA: Navigating an Evolving Federal Landscape Dec 21, 2023